Brooks ED - Search Results

1

Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene Therapy.

Yi H, Zhang Q, Brooks ED, Yang C, Thurberg BL, Kishnani PS, Sun B. Yi H, et al. Among authors: brooks ed. Hum Gene Ther. 2017 Mar;28(3):286-294. doi: 10.1089/hum.2016.099. Epub 2016 Nov 10. Hum Gene Ther. 2017. PMID: 27832700

2

Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.

Brooks ED, Little D, Arumugam R, Sun B, Curtis S, Demaster A, Maranzano M, Jackson MW, Kishnani P, Freemark MS, Koeberl DD. Brooks ED, et al. Mol Genet Metab. 2013 Jun;109(2):161-70. doi: 10.1016/j.ymgme.2013.03.018. Epub 2013 Apr 6. Mol Genet Metab. 2013. PMID: 23623482 Free PMC article.

3

Correction of glycogen storage disease type III with rapamycin in a canine model.

Yi H, Brooks ED, Thurberg BL, Fyfe JC, Kishnani PS, Sun B. Yi H, et al. Among authors: brooks ed. J Mol Med (Berl). 2014 Jun;92(6):641-50. doi: 10.1007/s00109-014-1127-4. Epub 2014 Feb 8. J Mol Med (Berl). 2014. PMID: 24509886

4

Large animal models and new therapies for glycogen storage disease.

Brooks ED, Koeberl DD. Brooks ED, et al. J Inherit Metab Dis. 2015 May;38(3):505-9. doi: 10.1007/s10545-014-9766-8. Epub 2014 Sep 16. J Inherit Metab Dis. 2015. PMID: 25224826 Free PMC article. Review.

5

Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade.

Han SO, Li S, Brooks ED, Masat E, Leborgne C, Banugaria S, Bird A, Mingozzi F, Waldmann H, Koeberl D. Han SO, et al. Among authors: brooks ed. Hum Gene Ther. 2015 Jan;26(1):26-35. doi: 10.1089/hum.2014.115. Hum Gene Ther. 2015. PMID: 25382056 Free PMC article.

6

Preclinical Development of New Therapy for Glycogen Storage Diseases.

Sun B, Brooks ED, Koeberl DD. Sun B, et al. Among authors: brooks ed. Curr Gene Ther. 2015;15(4):338-47. doi: 10.2174/1566523215666150630132253. Curr Gene Ther. 2015. PMID: 26122079 Free PMC article. Review.

7

In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA.

Landau DJ, Brooks ED, Perez-Pinera P, Amarasekara H, Mefferd A, Li S, Bird A, Gersbach CA, Koeberl DD. Landau DJ, et al. Among authors: brooks ed. Mol Ther. 2016 Apr;24(4):697-706. doi: 10.1038/mt.2016.35. Epub 2016 Feb 11. Mol Ther. 2016. PMID: 26865405 Free PMC article.

8

Natural Progression of Canine Glycogen Storage Disease Type IIIa.

Brooks ED, Yi H, Austin SL, Thurberg BL, Young SP, Fyfe JC, Kishnani PS, Sun B. Brooks ED, et al. Comp Med. 2016 Feb;66(1):41-51. Comp Med. 2016. PMID: 26884409 Free PMC article.

9

Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.

Brooks ED, Landau DJ, Everitt JI, Brown TT, Grady KM, Waskowicz L, Bass CR, D'Angelo J, Asfaw YG, Williams K, Kishnani PS, Koeberl DD. Brooks ED, et al. J Inherit Metab Dis. 2018 Nov;41(6):965-976. doi: 10.1007/s10545-018-0223-y. Epub 2018 Jul 24. J Inherit Metab Dis. 2018. PMID: 30043186 Free PMC article.

10

Letter to the Editors: Concerning "Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia" by Lee et al.

Brooks ED, Kishnani PS, Koeberl DD. Brooks ED, et al. J Inherit Metab Dis. 2018 Nov;41(6):913-914. doi: 10.1007/s10545-018-0248-2. Epub 2018 Sep 25. J Inherit Metab Dis. 2018. PMID: 30255460 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters